| abstract |
Provided are a class of five-membered heterocyclic pyridine compounds as represented by the following general formula (X), pharmaceutically acceptable salts or pharmaceutically acceptable solvates thereof, a preparation method thereof, pharmaceutical compositions containing the compounds, and the use of the compounds in preparing drugs for preventing and/or treating protein tyrosine kinase disorder-related diseases and tumours. |